VERONA PHARMA PLC's ticker is VRNA and the CUSIP is 925050106. A total of 43 filers reported holding VERONA PHARMA PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $138,000 | +23.2% | 13,446 | -50.6% | 0.07% | +35.2% |
| Q2 2022 | $112,000 | -37.4% | 27,196 | -23.7% | 0.05% | -18.2% |
| Q1 2022 | $179,000 | -21.8% | 35,656 | +4.5% | 0.07% | -14.3% |
| Q4 2021 | $229,000 | +26.5% | 34,106 | +2.9% | 0.08% | +16.7% |
| Q3 2021 | $181,000 | +74.0% | 33,156 | +113.8% | 0.07% | +61.0% |
| Q2 2021 | $104,000 | -11.9% | 15,506 | +10.0% | 0.04% | -18.0% |
| Q1 2021 | $118,000 | – | 14,102 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,457,499 | $16,932,000 | 5.79% |
| Aisling Capital Management LP | 1,332,485 | $9,327,000 | 1.60% |
| Ghost Tree Capital, LLC | 810,000 | $5,670,000 | 1.26% |
| Vivo Capital, LLC | 3,048,507 | $21,340,000 | 0.95% |
| NEA Management Company, LLC | 5,108,563 | $35,760,000 | 0.94% |
| Novo Holdings A/S | 2,608,755 | $18,261,000 | 0.78% |
| Samsara BioCapital, LLC | 1,111,112 | $7,778,000 | 0.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,033,603 | $7,235,000 | 0.64% |
| RA Capital Management | 5,100,000 | $31,824,000 | 0.44% |
| Orbimed Advisors | 5,694,841 | $39,864,000 | 0.35% |